**REGISTERED COMPANY NUMBER: CE017714 (England and Wales) REGISTERED CHARITY NUMBER: 1183723** ## **REPORT OF THE TRUSTEES AND** **UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024** ## **FOR** ## **HEART SUCCESS FOUNDATION** Centora James Limited **HEART SUCCESS FOUNDATION** ## **CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024** ||**Page**| |---|---| |**Report of the Trustees**|1| |**Statement of Financial Actvites**|3| |**Balance Sheet**|4| |**Notes to the Financial Statements**|5 to 6| |**Detailed Statement of Financial Actvites**|7| **HEART SUCCESS FOUNDATION** ## **REPORT OF THE TRUSTEES** ## **FOR THE YEAR ENDED 31 DECEMBER 2024** The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2024. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). ## **INCORPORATION** The charitable company was incorporated on 4 June 2019 and commenced trading on 1 May 2024. ## **STRUCTURE, GOVERNANCE AND MANAGEMENT Governing document** The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006. ## **REFERENCE AND ADMINISTRATIVE DETAILS** ## **Registered Company number** CE017714 (England and Wales) **Registered Charity number** 1183723 ## **Registered office** 70/2 Old Brompton Road London SW7 3DQ ## **Trustees** G Cotter (appointed 11.7.24) P M Volterrani (appointed 21.6.24) P O Chioncel (appointed 16.5.24) P A J Coats Prof. G M C Rosano ## **Charitable Activities** During the year, the Heart Success Foundation continued its pursuit to advance education, research, and collaboration in cardiovascular medicine. HSF provided endorsement support for the “Year in Cardiology” meeting held in Dubai in December 2024, organised by Dynamicom Education S.R.L. This international educational event brought together clinicians, researchers, and healthcare professionals to share the latest developments in cardiovascular care and clinical practice. HSF’s involvement ensured that high standards of scientific integrity and educational value were maintained, in line with our charitable objectives, to improve patient outcomes through professional education. The endorsement generated £6,000 in income, which was used to further HSF’s charitable purposes and to support future educational and initiatives in cardiovascular health. ## **Administration and Financial Overview** Administrative costs for the year included the engagement of one Manager at £2,000 per month, with NEST pension contributions commencing in September 2024. As the Foundation did not yet have sufficient funds during this period, GC Mavel covered these expenses through a monthly loan, which will be repaid in the next financial period following receipt of HSF’s first grant. Additional administrative and operational costs included: - Development of HSF’s website and social media channels - Website domain registration and Google Suite subscription to support communications and outreach activities **HEART SUCCESS FOUNDATION** ## **REPORT OF THE TRUSTEES - contnued FOR THE YEAR ENDED 31 DECEMBER 2024** These investments have strengthened HSF’s ability to communicate its mission, engage with stakeholders, and disseminate educational content effectively. HSF also initiated fundraising activities in 2024, successfully finalising its first grant agreements in 2025, providing the financial foundation for sustained charitable activity in the coming year. ## **Public Benefit Statement** The Trustees confirm that they have had regard to the Charity Commission’s guidance on public benefit in planning and carrying out HSF’s activities. By supporting and promoting high-quality educational events such as the “Year in Cardiology” meeting, HSF directly contributes to improving the research, understanding, prevention, and treatment of heart disease. Through its endorsement and educational engagement, HSF enables healthcare professionals to access up-to-date knowledge and research, which ultimately benefits patients and the wider public through improved standards of cardiovascular care. ## **Plans for the Next Year (FY 2025–2026)** In the coming year, HSF aims to build on its work in promoting cardiovascular research, education, and collaboration. The Foundation plans to: - Continue supporting international and regional educational initiatives that advance clinical knowledge and professional development in cardiology. - Expand its network of partnerships with medical societies, universities, and healthcare organisations to enhance the dissemination of evidence-based practices. - Encourage research dissemination by endorsing scientific meetings and educational programmes that contribute to improving patient outcomes in heart failure and related cardiovascular conditions. - Strengthen digital engagement, making educational resources more accessible to healthcare professionals worldwide, thereby broadening HSF’s public benefit. These plans will further HSF’s charitable objectives by ensuring that up-to-date, high-quality cardiovascular education continues to reach clinicians and, in turn, benefits the health and wellbeing of patients globally. Approved by order of the board of trustees on ............................................. and signed on its behalf by: .............................................................................. Prof. G M C Rosano - Trustee ggiuseppe rosanoiuseppe rosano (Oct 29, 2025 20:53:48 GMT) **HEART SUCCESS FOUNDATION** ## **STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2024** |||Unrestricted| |---|---|---| |||fund| ||Notes|£| |**INCOME AND ENDOWMENTS FROM**||| |Donatons and legacies||6,100| |**EXPENDITURE ON**||| |Raising funds||2,486| |Other||8,005| |**Total**||10,491| |**NET INCOME/(EXPENDITURE)**||(4,391)| |**TOTAL FUNDS CARRIED FORWARD**||(4,391)| The notes form part of these financial statements **HEART SUCCESS FOUNDATION** ## **BALANCE SHEET** ## **31 DECEMBER 2024** |||Unrestricted| |---|---|---| |||fund| ||Notes|£| |**CURRENT ASSETS**||| |Debtors|3|6,000| |Cash at bank||100| |||6,100| |**CREDITORS**||| |Amounts falling due within one year|4|(10,491)| |**NET CURRENT ASSETS/(LIABILITIES)**||(4,391)| |**TOTAL ASSETS LESS CURRENT LIABILITIES**||(4,391)| |**NET ASSETS**||(4,391)| |**FUNDS**|5|| |Unrestricted funds||(4,391)| |**TOTAL FUNDS**||(4,391)| The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024. The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006. - The trustees acknowledge their responsibilities for (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime. The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by: ggiuseppe rosanoiuseppe rosano (Oct 29, 2025 20:53:48 GMT) ............................................. G M C Rosano - Trustee The notes form part of these financial statements **HEART SUCCESS FOUNDATION** **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024** ## **1. ACCOUNTING POLICIES** ## **Basis of preparing the financial statements** The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. ## **Income** All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. ## **Expenditure** Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. ## **Taxation** The charity is exempt from corporation tax on its charitable activities. ## **Fund accounting** Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. ## **Pension costs and other post-retirement benefits** The charitable company operates a defined contribution pension scheme. Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate. ## **2. TRUSTEES' REMUNERATION AND BENEFITS** There were no trustees' remuneration or other benefits for the year ended 31 December 2024. ## **Trustees' expenses** There were no trustees' expenses paid for the year ended 31 December 2024. ## **3. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR** £ Trade debtors 6,000 continued... **HEART SUCCESS FOUNDATION** ## **NOTES TO THE FINANCIAL STATEMENTS - contnued FOR THE YEAR ENDED 31 DECEMBER 2024** ## **4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR** |**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**|| |---|---| |Social security and other taxes
Other creditors
Wages Payable
Loan from Trustee|£
1,149
176
2,000
7,166| ||10,491| ## **5. MOVEMENT IN FUNDS** |**MOVEMENT IN FUNDS**|||| |---|---|---|---| |||Net|| |||movement|At| |||in funds|31.12.24| |||£|£| |**Unrestricted funds**|||| |General fund||(4,391)|(4,391)| |**TOTAL FUNDS**||(4,391)|(4,391)| |Net movement in funds, included in the above are as follows:|||| ||Incoming|Resources|Movement| ||resources|expended|in funds| ||£|£|£| |**Unrestricted funds**|||| |General fund|6,100|(10,491)|(4,391)| |**TOTAL FUNDS**|6,100|(10,491)|(4,391)| ## **6. RELATED PARTY DISCLOSURES** There were no related party transactions for the year ended 31 December 2024. **HEART SUCCESS FOUNDATION** **DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2024** £ |**INCOME AND ENDOWMENTS**
**Donatons and legacies**
Donatons
Earned Income
**Total incoming resources**
**EXPENDITURE**
**Raising donatons and legacies**
Website Costs
**Support costs**
**Management**
Wages
Pensions
**Informaton technology**
IT Sofware and Consumables
Total resources expended
**Net expenditure**|100
6,000
6,100
6,100
2,486
7,250
75
7,325
680
10,491
(4,391)| |---|---| This page does not form part of the statutory financial statements